BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1501714)

  • 1. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
    Wulczyn FG; Naumann M; Scheidereit C
    Nature; 1992 Aug; 358(6387):597-9. PubMed ID: 1501714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
    Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
    Nature; 1992 Sep; 359(6393):339-42. PubMed ID: 1406939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
    Crenon I; Béraud C; Simard P; Montagne J; Veschambre P; Jalinot P
    Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subunit composition of NF-kappa B complexes changes during B-cell development.
    Grumont RJ; Gerondakis S
    Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
    Cressman DE; Taub R
    Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell leukemia virus type 1 tax protein increases NF-kappa B dimer formation and antagonizes the inhibitory activity of the I kappa B alpha regulatory protein.
    Petropoulos L; Lin R; Hiscott J
    Virology; 1996 Nov; 225(1):52-64. PubMed ID: 8918533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins.
    Inoue J; Takahara T; Akizawa T; Hino O
    Oncogene; 1993 Aug; 8(8):2067-73. PubMed ID: 8336935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor.
    Huguet C; Crepieux P; Laudet V
    Oncogene; 1997 Dec; 15(24):2965-74. PubMed ID: 9416840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
    Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
    Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
    Whiteside ST; Epinat JC; Rice NR; Israël A
    EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
    Naumann M; Nieters A; Hatada EN; Scheidereit C
    Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.
    Suzuki T; Hirai H; Yoshida M
    Oncogene; 1994 Nov; 9(11):3099-105. PubMed ID: 7936632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of nuclear factor-kappa B during primary B cell differentiation.
    Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
    J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.
    Schmid RM; Perkins ND; Duckett CS; Andrews PC; Nabel GJ
    Nature; 1991 Aug; 352(6337):733-6. PubMed ID: 1876189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
    Nolan GP; Fujita T; Bhatia K; Huppi C; Liou HC; Scott ML; Baltimore D
    Mol Cell Biol; 1993 Jun; 13(6):3557-66. PubMed ID: 8497270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.